to clarify the effectiveness of nicardipine , one of the dihydropyridine calcium-channel blockers , for myocardial protection during cold potassium cardioplegic arrest in pediatric cardiac surgery , a clinical trial of nicardipine ( 0.25 mg/l ) added to potassium cardioplegic solution was performed in children undergoing surgical repair of congenital heart diseases .
C0018787
cardiac
C0152021
of congenital heart diseases